Publikations-Highlights

Hier finden Sie eine Auswahl aktueller Publikationen von Forschungsgruppen unseres Departements in renommierten Fachjournalen.

Eine vollständige Liste von Publikationen mit Beteiligung von DKF-Mitarbeitenden finden Sie hier.

02. Mär 2022 / The Lancet Global Health

Fluvoxamine for the treatment of COVID-19.

01. Mär 2022 / Annals of Internal Medicine

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.

01. Mär 2022 / The Lancet Neurology

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.

25. Feb 2022 / Neurol Neuroimmunol Neuroinflamm

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis.

22. Feb 2022 / European Heart Journal

Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?

17. Feb 2022 / European Heart Journal

Silent brain infarcts impact on cognitive function in atrial fibrillation.

03. Feb 2022 / JAMA Ophthalmology

Complement Inhibition in Age-Related Macular Degeneration-Treat Early!

27. Jan 2022 / JAMA Ophthalmology

Pentosan and Macular Disease-A Causal Association?

21. Jan 2022 / Science

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.

11. Jan 2022 / Immunity

Inflammation in obesity, diabetes, and related disorders.